October PharmaE has been growing earnings at an average annual rate of 9.7%, while the Pharmaceuticals industry saw earnings growing at 22.2% annually. Revenues have been growing at an average rate of 21.1% per year. October PharmaE's return on equity is 28%, and it has net margins of 11.3%.
Key information
9.67%
Earnings growth rate
9.52%
EPS growth rate
Pharmaceuticals Industry Growth
9.80%
Revenue growth rate
21.06%
Return on equity
27.97%
Net Margin
11.29%
Last Earnings Update
30 Sep 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How October PharmaE makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
CASE:OCPH Revenue, expenses and earnings (EGP Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Sep 25
1,462
165
223
0
30 Jun 25
1,413
141
216
0
31 Mar 25
1,340
138
196
0
31 Dec 24
1,228
131
184
0
30 Sep 24
1,193
158
181
0
30 Jun 24
1,130
175
184
0
31 Mar 24
1,073
172
176
0
31 Dec 23
1,012
150
170
0
30 Sep 23
891
131
162
0
30 Jun 23
809
117
153
0
31 Mar 23
761
110
149
0
31 Dec 22
727
114
142
0
30 Sep 22
709
114
138
0
30 Jun 22
695
105
132
0
31 Mar 22
669
111
130
0
31 Dec 21
655
120
124
0
30 Sep 21
651
123
125
0
30 Jun 21
619
131
108
0
31 Mar 21
589
121
100
0
31 Dec 20
543
88
105
0
30 Sep 20
527
79
100
0
30 Jun 20
527
62
110
0
31 Mar 20
529
38
117
0
31 Dec 19
523
34
113
0
30 Sep 19
499
17
109
0
30 Jun 19
462
8
103
0
31 Mar 19
426
18
90
0
31 Dec 18
401
18
89
0
30 Sep 18
355
21
83
0
30 Jun 18
339
25
91
0
31 Mar 18
346
34
100
0
31 Dec 17
350
45
99
0
30 Sep 17
351
52
112
0
30 Jun 17
337
50
104
0
31 Mar 17
302
42
95
0
31 Dec 16
288
35
95
0
30 Sep 16
266
24
85
0
30 Jun 16
256
19
87
0
31 Mar 16
258
20
87
0
31 Dec 15
244
16
84
0
30 Sep 15
239
22
76
0
30 Jun 15
231
17
78
0
Quality Earnings: OCPH has high quality earnings.
Growing Profit Margin: OCPH's current net profit margins (11.3%) are lower than last year (13.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OCPH's earnings have grown by 9.7% per year over the past 5 years.
Accelerating Growth: OCPH's earnings growth over the past year (4.4%) is below its 5-year average (9.7% per year).
Earnings vs Industry: OCPH earnings growth over the past year (4.4%) did not outperform the Pharmaceuticals industry 31.5%.
Return on Equity
High ROE: OCPH's Return on Equity (28%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/15 07:25
End of Day Share Price
2026/06/15 00:00
Earnings
2025/09/30
Annual Earnings
2024/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
October Pharma S.A.E is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.